Editorial: Unveiling biomarkers and mechanisms in the tumor-immune nexus.
Chenfeng Ma, Wantao Wu, Pengpeng Zhang, Jiaheng Xie
Author Information
- Chenfeng Ma: Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China.
- Wantao Wu: Department of Thyroid and Breast Surgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
- Pengpeng Zhang: Department of Lung Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
- Jiaheng Xie: Department of Plastic Surgery, Xiangya Hospital, Central South University, Changsha, China.
No abstract text available.
- Nat Rev Cancer. 2020 Apr;20(4):203-217
[PMID: 32161398]
- Exp Mol Med. 2018 Dec 13;50(12):1-11
[PMID: 30546008]
- Front Immunol. 2020 Dec 03;11:583084
[PMID: 33365025]
- Immunity. 2021 May 11;54(5):859-874
[PMID: 33838745]
- Protein Cell. 2021 May;12(5):426-435
[PMID: 33296049]
- Cancer Lett. 2020 Feb 1;470:126-133
[PMID: 31730903]
- Biomed Pharmacother. 2022 Jul;151:113068
[PMID: 35676780]
- Mol Cancer. 2021 Oct 11;20(1):131
[PMID: 34635121]
- Immunity. 2023 Oct 10;56(10):2206-2217
[PMID: 37703879]
- Cancer Cell. 2022 Feb 14;40(2):201-218.e9
[PMID: 35090594]
- Front Immunol. 2023 Aug 24;14:1212476
[PMID: 37691932]
- Trends Cancer. 2020 Jul;6(7):605-618
[PMID: 32610070]
- Front Immunol. 2021 Mar 09;12:636568
[PMID: 33767702]
